LetterEur Radiol2026
Reply to the Letter to the Editor: Methodological and biophysical concerns on quantitative DCE-MRI for early PDAC response assessment.
- Journal
- Eur Radiol
- Published
- 16 October 2026
- Citations
- 0
- Type
- Letter
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 4
- DCE-MRI guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer R01CA290435↗
- ProAgio in Pancreatic Cancer R01CA294647↗
- Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response UG3CA232820↗
- Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response UH3CA232820↗